Results 21 to 30 of about 533,276 (294)

Mitochondrial disease in children [PDF]

open access: yesJournal of Internal Medicine, 2020
AbstractMitochondrial disease presenting in childhood is characterized by clinical, biochemical and genetic complexity. Some children are affected by canonical syndromes, but the majority have nonclassical multisystemic disease presentations involving virtually any organ in the body.
openaire   +2 more sources

The Guanylyl Cyclase Activator YC-1 Directly Inhibits the Voltage-Dependent K+ Channels in Rabbit Coronary Arterial Smooth Muscle Cells

open access: yesJournal of Pharmacological Sciences, 2010
We investigated the effects of YC-1, an activator of soluble guanylyl cyclase (sGC), on voltage-dependent K+ (Kv) channels in smooth muscle cells from freshly isolated rabbit coronary arteries by using the whole-cell patch clamp technique. YC-1 inhibited
Won Sun Park   +9 more
doaj   +1 more source

Mitochondrial Dynamics in Mitochondrial Diseases

open access: yesDiseases, 2016
Mitochondria are very versatile organelles in continuous fusion and fission processes in response to various cellular signals. Mitochondrial dynamics, including mitochondrial fission/fusion, movements and turnover, are essential for the mitochondrial network quality control.
Juan Suárez-Rivero   +9 more
openaire   +3 more sources

Oral delivery of carrier-free dual-drug nanocrystal self-assembled microspheres improved NAD+ bioavailability and attenuated cardiac ischemia/reperfusion injury in mice

open access: yesDrug Delivery, 2021
Nicotinamide riboside (NR), as a dietary supplement, can be converted to nicotinamide adenine dinucleotide (NAD+) in cells to support mitochondrial energy metabolism.
Hongfei Nie   +5 more
doaj   +1 more source

A Novel Atypical PKC-Iota Inhibitor, Echinochrome A, Enhances Cardiomyocyte Differentiation from Mouse Embryonic Stem Cells

open access: yesMarine Drugs, 2018
Echinochrome A (EchA) is a marine bioproduct extracted from sea urchins having antioxidant, antimicrobial, anti-inflammatory, and chelating effects, and is the active component of the clinical drug histochrome.
Hyoung Kyu Kim   +11 more
doaj   +1 more source

Variable effects of omaveloxolone (RTA408) on primary fibroblasts with mitochondrial defects

open access: yesFrontiers in Molecular Biosciences, 2022
Omaveloxolone (RTA408) is a second-generation oleanane triterpenoid Nrf2 inducer with antioxidant and anti-inflammatory properties and was reported to improve mitochondrial bioenergetics.
Madleen Zighan   +10 more
doaj   +1 more source

Mitochondrial Diseases

open access: yesJournal of Epilepsy Research, 1970
Mitochondria contain the respiratory chain enzyme complexes that carry out oxidative phosphorylation and produce the main part of cellular energy in the form of ATP. Although several proteins related with signalling, assembling, transporting, and enzymatic function can be impaired in mitochondrial diseases, most frequently the activity of the ...
openaire   +2 more sources

Mitochondrial disease in flies

open access: yesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2004
The Drosophila mutant technical knockout (tko), affecting the mitochondrial protein synthetic apparatus, exhibits respiratory chain deficiency and a phenotype resembling various features of mitochondrial disease in humans (paralytic seizures, deafness, developmental retardation).
Jacobs, Howard T.   +5 more
openaire   +2 more sources

Mitochondrial diseases and epilepsy [PDF]

open access: yesEpilepsia, 2012
SummaryThe mitochondrial respiratory chain is the final common pathway for energy production. Defects affecting this pathway can give rise to disease that presents at any age and affects any tissue. However, irrespective of genetic defect, epilepsy is common and there is a significant risk of status epilepticus.
Laurence A, Bindoff, Bernt A, Engelsen
openaire   +2 more sources

Treatment for mitochondrial diseases [PDF]

open access: yesReviews in the Neurosciences, 2020
Abstract Mitochondrial diseases are predominantly caused by mutations of mitochondrial or nuclear DNA, resulting in multisystem defects. Current treatments are largely supportive, and the disorders progress relentlessly. Nutritional supplements, pharmacological agents and physical therapies have been used in different clinical trials ...
Tongling, Liufu, Zhaoxia, Wang
openaire   +2 more sources

Home - About - Disclaimer - Privacy